OBJECTIVES: The objectives of this study were to determine patterns of contraceptive utilization among sexually active HIV-1-seropositive women postpartum and to identify correlates of hormonal contraception uptake. GOAL: The goal of this study was to improve delivery of family planning services to HIV-1-infected women in resource-limited settings. STUDY DESIGN: HIV-1-infected pregnant women were followed prospectively in a perinatal HIV-1 transmission study. Participants were referred to local clinics for contraceptive counseling and management. RESULTS: Among 319 HIV-1-infected women, median time to sexual activity postpartum was 2 months and 231 (72%) women used hormonal contraception for at least 2 months during follow-up, initiating use at approximately 3 months postpartum (range, 1-11 months). Overall, 101 (44%) used DMPA, 71 (31%) oral contraception, and 59 (25%) switched methods during follow-up. Partner notification, infant mortality, and condom use were similar between those using and not using contraception. CONCLUSIONS: Using existing the healthcare infrastructure, it is possible to achieve high levels of postpartum hormonal contraceptive utilization among HIV-1-seropositive women.
OBJECTIVES: The objectives of this study were to determine patterns of contraceptive utilization among sexually active HIV-1-seropositivewomen postpartum and to identify correlates of hormonal contraception uptake. GOAL: The goal of this study was to improve delivery of family planning services to HIV-1-infectedwomen in resource-limited settings. STUDY DESIGN:HIV-1-infected pregnant women were followed prospectively in a perinatal HIV-1 transmission study. Participants were referred to local clinics for contraceptive counseling and management. RESULTS: Among 319 HIV-1-infectedwomen, median time to sexual activity postpartum was 2 months and 231 (72%) women used hormonal contraception for at least 2 months during follow-up, initiating use at approximately 3 months postpartum (range, 1-11 months). Overall, 101 (44%) used DMPA, 71 (31%) oral contraception, and 59 (25%) switched methods during follow-up. Partner notification, infant mortality, and condom use were similar between those using and not using contraception. CONCLUSIONS: Using existing the healthcare infrastructure, it is possible to achieve high levels of postpartum hormonal contraceptive utilization among HIV-1-seropositivewomen.
Authors: Carey Farquhar; James N Kiarie; Barbra A Richardson; Marjory N Kabura; Francis N John; Ruth W Nduati; Dorothy A Mbori-Ngacha; Grace C John-Stewart Journal: J Acquir Immune Defic Syndr Date: 2004-12-15 Impact factor: 3.731
Authors: Carey Farquhar; Thomas C VanCott; Dorothy A Mbori-Ngacha; Lena Horani; Rose K Bosire; Joan K Kreiss; Barbra A Richardson; Grace C John-Stewart Journal: J Infect Dis Date: 2002-09-20 Impact factor: 5.226
Authors: Carey Farquhar; Sarah Rowland-Jones; Dorothy Mbori-Ngacha; Mary Redman; Barbara Lohman; Jennifer Slyker; Phelgona Otieno; Elizabeth Obimbo; Timothy Rostron; James Ochieng; Julius Oyugi; Rose Bosire; Grace John-Stewart Journal: AIDS Res Hum Retroviruses Date: 2004-07 Impact factor: 2.205
Authors: Catherine S Todd; Tracy C Anderman; Sarah Long; Landon Myer; Linda-Gail Bekker; Gregory A Petro; Heidi E Jones Journal: Contraception Date: 2018-02-09 Impact factor: 3.375
Authors: Lisa B Haddad; Caryl Feldacker; Denise J Jamieson; Hannock Tweya; Carrie Cwiak; Thomas Chaweza; Linly Mlundira; Jane Chiwoko; Bernadette Samala; Fanny Kachale; Amy G Bryant; Mina C Hosseinipour; Gretchen S Stuart; Irving Hoffman; Sam Phiri Journal: PLoS One Date: 2015-03-26 Impact factor: 3.240
Authors: Matthew F Chersich; Nicole Kley; Stanley M F Luchters; Carol Njeru; Elodie Yard; Mary J Othigo; Marleen Temmerman Journal: BMC Pregnancy Childbirth Date: 2009-11-05 Impact factor: 3.007